Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Plotnikov

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Molecular and Cellular Biology|February 3, 2016
A Novel Allosteric Mechanism of NF-κB Dimerization and DNA Binding Targeted by an Anti-Inflammatory DrugShaked Ashkenazi, Alexander Plotnikov, Anat Bahat, et al.
Molecular Endocrinology (Baltimore, Md.)|October 22, 2010
Prolactin inhibits activity of pyruvate kinase M2 to stimulate cell proliferationBentley Varghese, Gayathri Swaminathan, Alexander Plotnikov, et al.
International Journal of Molecular Sciences|September 16, 2017
The Role of ERK Signaling in Experimental Autoimmune EncephalomyelitisKatharina Birkner, Beatrice Wasser, Julia Loos, et al.
Cancer Research|March 5, 2008
Oncogene-mediated inhibition of glycogen synthase kinase 3 beta impairs degradation of prolactin receptorAlexander Plotnikov, Ying Li, Thai H Tran, et al.
The EMBO Journal|May 12, 2025
Inhibitors of eIF1A-ribosome interaction unveil uORF-dependent regulation of translation initiation and antitumor and antiviral effectsDaniel Hayat, Ariel Ogran, Shaked Ashkenazi, et al.
Stem Cell Research|July 31, 2017
A multiplexed screening method for pluripotencyAlexander Plotnikov, Noga Kozer, Vladislav Krupalnik, et al.
Biochemical and Biophysical Research Communications|January 2, 2008
Ligand-independent pathway that controls stability of interferon alpha receptorJianghuai Liu, Alexander Plotnikov, Anamika Banerjee, et al.
Nature Communications|March 31, 2015
The nuclear translocation of ERK1/2 as an anticancer targetAlexander Plotnikov, Karen Flores, Galia Maik-Rachline, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2022
Inhibitors of eIF4G1-eIF1 uncover its regulatory role of ER/UPR stress-response genes independent of eIF2α-phosphorylationUrmila Sehrawat, Ora Haimov, Benjamin Weiss, et al.
Elife|August 2, 2024
Dual targeting of histone deacetylases and MYC as potential treatment strategy for H3-K27M pediatric gliomasDanielle Algranati, Roni Oren, Bareket Dassa, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Molecular and Cellular Biology|February 3, 2016
A Novel Allosteric Mechanism of NF-κB Dimerization and DNA Binding Targeted by an Anti-Inflammatory DrugShaked Ashkenazi, Alexander Plotnikov, Anat Bahat, et al.
Molecular Endocrinology (Baltimore, Md.)|October 22, 2010
Prolactin inhibits activity of pyruvate kinase M2 to stimulate cell proliferationBentley Varghese, Gayathri Swaminathan, Alexander Plotnikov, et al.
International Journal of Molecular Sciences|September 16, 2017
The Role of ERK Signaling in Experimental Autoimmune EncephalomyelitisKatharina Birkner, Beatrice Wasser, Julia Loos, et al.
Cancer Research|March 5, 2008
Oncogene-mediated inhibition of glycogen synthase kinase 3 beta impairs degradation of prolactin receptorAlexander Plotnikov, Ying Li, Thai H Tran, et al.
The EMBO Journal|May 12, 2025
Inhibitors of eIF1A-ribosome interaction unveil uORF-dependent regulation of translation initiation and antitumor and antiviral effectsDaniel Hayat, Ariel Ogran, Shaked Ashkenazi, et al.
Stem Cell Research|July 31, 2017
A multiplexed screening method for pluripotencyAlexander Plotnikov, Noga Kozer, Vladislav Krupalnik, et al.
Biochemical and Biophysical Research Communications|January 2, 2008
Ligand-independent pathway that controls stability of interferon alpha receptorJianghuai Liu, Alexander Plotnikov, Anamika Banerjee, et al.
Nature Communications|March 31, 2015
The nuclear translocation of ERK1/2 as an anticancer targetAlexander Plotnikov, Karen Flores, Galia Maik-Rachline, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2022
Inhibitors of eIF4G1-eIF1 uncover its regulatory role of ER/UPR stress-response genes independent of eIF2α-phosphorylationUrmila Sehrawat, Ora Haimov, Benjamin Weiss, et al.
Elife|August 2, 2024
Dual targeting of histone deacetylases and MYC as potential treatment strategy for H3-K27M pediatric gliomasDanielle Algranati, Roni Oren, Bareket Dassa, et al.
Pageof 4